Table 1.
Means, Standard Deviations and Ranges for the Clinical and N-back Task Data
Sample Size | Range | Mean | SD | |
---|---|---|---|---|
General Cognitive Status | ||||
RBANSa | ||||
Immediate Memory | 35 | 69 – 126 | 102.37 | 13.65 |
Visuospatial Construction | 35 | 58 – 112 | 87.43 | 14.54 |
Language | 35 | 85 – 127 | 102.09 | 11.97 |
Attention | 35 | 72 – 138 | 102.57 | 15.85 |
Delayed Memory | 35 | 68 – 130 | 100.94 | 12.29 |
Global Cognitive Status (total) | 35 | 80 – 122 | 98.09 | 11.20 |
Objective Measures | ||||
Executive Functioning: D-KEFS | ||||
Letter Fluency | 35 | 18 – 58 | 39.66 | 9.66 |
Design Fluency | 35 | 14 – 43 | 25.29 | 7.23 |
Executive Compositeb | 35 | −2.70 – 3.24 | .00 | 1.57 |
Prospective Memory | ||||
Hidden Objects | 32 | 0 – 3 | 2.13 | .91 |
Activity Paradigm | 32 | 0 – 8 | 6.26 | 2.59 |
Prospective Memory Total | 32 | 0 – 11 | 8.39 | 3.01 |
Performance-based Functional Status | ||||
ILS Managing Home | 17 | 20 – 29 | 26.53 | 2.67 |
ILS Health & Safety | 17 | 31 – 38 | 34.06 | 2.22 |
Functional Status Compositeb | 17 | −3.37 – 2.70 | .00 | 1.79 |
Self-Report Measures | ||||
Cognitive Failures | ||||
DEXc | 30 | 1 – 28 | 11.19 | 7.82 |
PRMQc | 30 | 20 – 51 | 33.87 | 7.20 |
Cognitive Failures Compositeb | 30 | −3.10 – 4.40 | .00 | 1.84 |
Self-report Functional Status | ||||
IADL-Cc | 30 | 27 – 62 | 36.99 | 8.86 |
N-back Task Variables | ||||
Clinical Averaged | 35 | 11 – 33 | 23.44 | 5.55 |
Asymptotee | 35 | 24 – 40 | 33.53 | 4.14 |
EMA Average | 35 | 22 – 41 | 33.19 | 4.30 |
IIVc | 35 | .83 – 3.11 | 1.86 | .53 |
Note. RBANS = Repeatable battery for the assessment of neuropsychology status; D-KEFS = Delis-Kaplan Executive Function System; PM = Prospective Memory; DEX = Dysexecutive Questionnaire; PRMQ = Prospective and Retrospective Memory Questionnaire; ILS = Independent Living Scale; IADL-C = Instrumental Activities of Daily Living: Compensation; EMA = Ecological Momentary Assessment; IIV = intra-individual variability
Presented as scaled scores,
Presented as z-scores,
Higher score = poorer performance,
n-back practice trials 1–10,
n-back practice trials 91–100